Cancer, Ovarian
14
3
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Family History App in Personalized Medicine
Survivors Uniting for Remote Guided Exercise
WellSpan-THRIVE Cancer QOL Study
A Study to Evaluate Folate Receptor Alpha (FRα) Expression in Adult Participants With Ovarian, Fallopian Tube, and Primary Peritoneal Cancer in Italy
Interventions to Decrease Financial Toxicity
Abdominopelvic Cancer Prehabilitation
Quest to Analyze One Thousand Humans Meditating
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer
Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs